Stock CDNA CAREDX, INC
Add to a list
To use this feature you must be a member
Log inSign up

News CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
13.01 USD -3.77% Intraday chart for CareDx, Inc -18.38% +8.42%
May. 30 CareDx, Inc Announces New Data to Be Presented At the 2024 American Transplant Congress CI
May. 17 Craig-Hallum Adjusts Price Target on CareDx to $22 From $15, Maintains Buy Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CareDx Reiterates Position that it Does Not Infringe the 544 Patent, Injunction Motion is Irrelevant
AQ
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
BU
CareDx, Inc Announces New Data to Be Presented At the 2024 American Transplant Congress
CI
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
BU
CareDx to Participate in Upcoming Investor Conferences
BU
Craig-Hallum Adjusts Price Target on CareDx to $22 From $15, Maintains Buy Rating
MT
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
BU
Study Shows CareDx, Inc.?s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
CI
Raymond James Downgrades CareDx to Market Perform From Outperform
MT
CareDx : 2024 Proxy Statement
PU
Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating
MT
Sector Update: Health Care Stocks Higher Late Afternoon
MT
CareDx Shares Rise After Q1 Results Beat Estimates
MT
CareDx: Q1 Earnings Snapshot
AQ
Earnings Flash (CDNA) CAREDX Reports Q1 Revenue $72M, vs. Street Est of $63.1M
MT
Transcript : CareDx, Inc, Q1 2024 Earnings Call, May 09, 2024
CareDx Reports First Quarter 2024 Results
BU
CareDx, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CareDx Raises Revenue Guidance for the Year 2024
CI
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CDNA Stock
  4. News CareDx, Inc